An Orally Bioavailable, Indole-3-glyoxylamide Based Series of Tubulin Polymerization Inhibitors Showing Tumor Growth Inhibition in a Mouse Xenograft Model of Head and Neck Cancer.

MLA

Colley, Helen E., et al. “An Orally Bioavailable, Indole-3-Glyoxylamide Based Series of Tubulin Polymerization Inhibitors Showing Tumor Growth Inhibition in a Mouse Xenograft Model of Head and Neck Cancer.” Journal of Medicinal Chemistry, vol. 58, no. 23, Dec. 2015, pp. 9309–33. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.5b01312.

APA

Colley, H. E., Muthana, M., Danson, S. J., Jackson, L. V., Brett, M. L., Harrison, J., Coole, S. F., Mason, D. P., Jennings, L. R., Melanie Wong, Tulasi, V., Norman, D., Lockey, P. M., Williams, L., Dossetter, A. G., Griffen, E. J., & Thompson, M. J. (2015). An Orally Bioavailable, Indole-3-glyoxylamide Based Series of Tubulin Polymerization Inhibitors Showing Tumor Growth Inhibition in a Mouse Xenograft Model of Head and Neck Cancer. Journal of Medicinal Chemistry, 58(23), 9309–9333. https://doi.org/10.1021/acs.jmedchem.5b01312

Chicago

Colley, Helen E., Munitta Muthana, Sarah J. Danson, Lucinda V. Jackson, Matthew L. Brett, Joanne Harrison, Sean F. Coole, et al. 2015. “An Orally Bioavailable, Indole-3-Glyoxylamide Based Series of Tubulin Polymerization Inhibitors Showing Tumor Growth Inhibition in a Mouse Xenograft Model of Head and Neck Cancer.” Journal of Medicinal Chemistry 58 (23): 9309–33. doi:10.1021/acs.jmedchem.5b01312.